MSN launches beta health management site

Share this article:
MSN launches beta health management site
MSN launches beta health management site

MSN today announced the launch of My Health Info, a new website for consumers that incorporates Microsoft's HealthVault profiles into a more comprehensive offering, which includes tools and widgets to organize health information.

The site, located on MSN's health and fitness homepage, provides tools for monitoring condition specific variables, such as high blood pressure or diabetes, as well as general health stats, such as body-mass index. Consumers can customize individual dashboards by adding or deleting widgets. Advertising and sponsorships will be incorporated into the site eventually, once My Health Info concludes its testing phase, according to Lisa Gurry, director, MSN.

The website also offers savings on HealthVault-enabled devices, such as free delivery or rebates on pedometers and blood pressure monitors. The site allows caregivers to access profiles of multiple family members at one time, and delivers health news based on topics of interest. The site isn't available on mobile devices yet, but Gurry expects Microsoft Silverlight, a multi-platform video and graphics technology and partner on My Health Info, to add that capability moving forward. IQ Interactive's Atlanta, Georgia office also worked on the design and engineering of the site.

“Building on the power of HealthVault, My Health Info demonstrates how we are continuing to provide consumers with the trusted and relevant tools they need to make more informated decisions in support of their health and the health of their families,” said David Cerino, general manager of consumer health, Microsoft health solutions group, in a statement.

Share this article:

Email Newsletters

More in News

Sanofi tightens PCSK9 race, exceeds Q2 expectations

Sanofi tightens PCSK9 race, exceeds Q2 expectations

Sanofi and partner Regeneron attached a $67.5-million priority review voucher to their experimental cholesterol drug alirocumab, making for a tighter race with Amgen.

HHS shows how diabetes adds up

HHS shows how diabetes adds up

A 2005-to-2010 survey shows diabetics 65-and-up juggle at least four co-morbid conditions and five medications for them.

AstraZenca beefs up respiratory portfolio

AstraZenca beefs up respiratory portfolio

AstraZeneca has made an $875-million move to beef up its respiratory pipeline by making Almirall's lineup its own.